Literature DB >> 8522320

Detection of chromosome aberrations in paraffin sections of seven gonadal yolk sac tumors of childhood.

J Jenderny, E Köster, A Meyer, O Borchers, W Grote, D Harms, U Jänig.   

Abstract

Yolk sac tumors are the most frequent kind of malignant pediatric germ cell tumor and may have a fundamentally different pathogenesis than adult germ cell tumors. Since few cytogenetic studies have been performed so far, in situ hybridization was applied to interphase cell nuclei of seven gonadal yolk sac tumors of childhood in routine paraffin-embedded tissue sections. The panel of chromosome-specific DNA probes was selected on the basis of their relevance in adult germ cell tumors and consisted of five DNA probes specific for the (peri)centromeric regions of chromosomes 1, 8, 12, 17 and/or X and/or one DNA probe specific for the subtelomeric region of chromosome 1 (p36.3). As in adult germ cell tumors, all pediatric gonadal yolk sac tumors had an increased incidence of numerical chromosome aberrations. All tumors showed an overrepresentation of at least three chromosomes. Gains of chromosome 12, which is highly specific in adult germ cell tumors, were diagnosed in six pediatric gonadal yolk sac tumors. The DNA indices determined in the paraffin-embedded tumor material correlated well with the in situ hybridization findings. A chromosome was either over- or underrepresented, compared with the corresponding DNA indices, in only a few cases. The short arm of chromosome 1 in adult germ cell tumors is often involved in structural aberrations. In pediatric germ cell tumors, the short arm of chromosome 1 is also a nonrandom site of structural aberrations. Moreover, the presence of a deletion at 1p36.3 in four out of five tumors suggests that the loss of gene(s) in this region is an important event in the pathogenesis of gonadal yolk sac tumors of childhood.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8522320     DOI: 10.1007/bf00210292

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  37 in total

1.  Karyotyping and DNA flow cytometry of metastatic ovarian yolk sac tumor.

Authors:  A Vos; J W Oosterhuis; B de Jong; S M Castedo; H Hollema; J Buist; J G Aalders
Journal:  Cancer Genet Cytogenet       Date:  1990-02

2.  Localization and polymorphism of a chromosome 12-specific alpha satellite DNA sequence.

Authors:  L H Looijenga; V T Smit; J W Wessels; P Mollevanger; J W Oosterhuis; C J Cornelisse; P Devilee
Journal:  Cytogenet Cell Genet       Date:  1990

3.  Detection of numerical and structural chromosome abnormalities in pediatric germ cell tumors by means of interphase cytogenetics.

Authors:  C Stock; I M Ambros; T Lion; O A Haas; A Zoubek; H Gadner; P F Ambros
Journal:  Genes Chromosomes Cancer       Date:  1994-09       Impact factor: 5.006

4.  3-Aminopropyltriethoxysilane (APES): a new advance in section adhesion.

Authors:  P H Maddox; D Jenkins
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

5.  X-chromatin, sex chromosomes, and ploidy in 37 germ cell tumors of the testis.

Authors:  N B Atkin; M C Baker
Journal:  Cancer Genet Cytogenet       Date:  1992-03

6.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

7.  Two distinct regions involved in 1p deletion in human primary breast cancer.

Authors:  I Bièche; M H Champème; F Matifas; C S Cropp; R Callahan; R Lidereau
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

8.  Cloning of human satellite III DNA: different components are on different chromosomes.

Authors:  H J Cooke; J Hindley
Journal:  Nucleic Acids Res       Date:  1979-07-25       Impact factor: 16.971

9.  Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.

Authors:  J F Moley; M B Brother; C T Fong; P S White; S B Baylin; B Nelkin; S A Wells; G M Brodeur
Journal:  Cancer Res       Date:  1992-02-15       Impact factor: 12.701

10.  Allelic loss at 1p is associated with tumor progression of meningiomas.

Authors:  M J Bello; J M de Campos; M E Kusak; J Vaquero; J L Sarasa; A Pestaña; J A Rey
Journal:  Genes Chromosomes Cancer       Date:  1994-04       Impact factor: 5.006

View more
  6 in total

Review 1.  Molecular genetics of pineal region neoplasms.

Authors:  M D Taylor; T G Mainprize; J A Squire; J T Rutka
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

Review 2.  Interphase cytogenetics on paraffin sections of paediatric extragonadal yolk sac tumours.

Authors:  J Jenderny; E Köster; O Borchers; A Meyer; W Grote; D Harms; U Jänig
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

3.  Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants.

Authors:  Noriko Kato; Gen Tamura; Masayuki Fukase; Hiroyuki Shibuya; Teiichi Motoyama
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

Review 4.  Germinoma in the basal ganglia with an abnormal karyotype: case report and review of the literature.

Authors:  En Xu; Xiaojuan Wang; Zhuofang Hao; Zheng Chen; Xuefen Lu
Journal:  Childs Nerv Syst       Date:  2009-10-30       Impact factor: 1.475

5.  Malignant germ cell tumours of childhood: new associations of genomic imbalance.

Authors:  R D Palmer; N A Foster; S L Vowler; I Roberts; C M Thornton; J P Hale; D T Schneider; J C Nicholson; N Coleman
Journal:  Br J Cancer       Date:  2007-02-06       Impact factor: 7.640

Review 6.  Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis.

Authors:  Sigrid Marie Kraggerud; Christina E Hoei-Hansen; Sharmini Alagaratnam; Rolf I Skotheim; Vera M Abeler; Ewa Rajpert-De Meyts; Ragnhild A Lothe
Journal:  Endocr Rev       Date:  2013-04-10       Impact factor: 19.871

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.